Hu JS - Search Results

1

[Expression of pituitary tumor transforming gene in patients with AML].

Wang Z, Lu QY, Niu XQ, Zhang P, Zhao JN, Zhang KJ, Li P, Hu JS. Wang Z, et al. Among authors: hu js. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1427-30. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21176344 Chinese.

2

Notch1 signaling inhibits growth of EC109 esophageal carcinoma cells through downmodulation of HPV18 E6/E7 gene expression.

Zhang KJ, Lu QY, Niu XQ, Zhang P, Zhao JN, Wang Z, Hu JS, Li P, Liu WL. Zhang KJ, et al. Among authors: hu js. Acta Pharmacol Sin. 2009 Feb;30(2):153-8. doi: 10.1038/aps.2008.16. Epub 2009 Jan 5. Acta Pharmacol Sin. 2009. PMID: 19122673 Free PMC article.

3

Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway.

Hu J, Huang X, Hong X, Lu Q, Zhu X. Hu J, et al. Cancer Cell Int. 2013 Mar 13;13(1):25. doi: 10.1186/1475-2867-13-25. Cancer Cell Int. 2013. PMID: 23497375 Free PMC article.

4

Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action.

Hu J, Zhu X, Lu Q. Hu J, et al. J Int Med Res. 2013 Aug;41(4):1017-26. doi: 10.1177/0300060513485912. Epub 2013 Jul 9. J Int Med Res. 2013. PMID: 23839278 Free article.

5

[Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line].

Lu YY, Xiao CR, Chen HY, Huang X, Hu JS, Lu QY. Lu YY, et al. Among authors: hu js. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1336-40. doi: 10.7534/j.issn.1009-2137.2014.05.029. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25338584 Chinese.

6

Saliva as a sampling source for the detection of leukemic fusion transcripts.

Chen D, Song N, Ni R, Zhao J, Hu J, Lu Q, Li Q. Chen D, et al. J Transl Med. 2014 Nov 19;12:321. doi: 10.1186/s12967-014-0321-z. J Transl Med. 2014. PMID: 25407125 Free PMC article.

7

Acute monocytic leukaemia with t(11; 12) (p15; q13) chromosomal changes: A case report and literature review.

Hu J, Hong X, Li Z, Lu Q. Hu J, et al. Oncol Lett. 2015 Oct;10(4):2307-2310. doi: 10.3892/ol.2015.3511. Epub 2015 Jul 20. Oncol Lett. 2015. PMID: 26622840 Free PMC article.

8

[Targeting miR155 restores chemotherapy sensitivity in drug-resistant myeloma cell-line RPMI8226/DOX cells].

Xiao CR, Hong XL, Hu JS, Chen YM, Lu QY. Xiao CR, et al. Among authors: hu js. Zhonghua Xue Ye Xue Za Zhi. 2017 Jan 14;38(1):55-59. doi: 10.3760/cma.j.issn.0253-2727.2017.01.012. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28219227 Free PMC article. Chinese.

9

[Effect of Hedgehog Signaling Pathway Abnormality on Chemothe-rapeutic Resistance of Multiple Myeloma].

Hu JS, Huang X, Huang YD, Lu YY, Lu QY. Hu JS, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):465-470. doi: 10.7534/j.issn.1009-2137.2017.02.028. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28446294 Chinese.

10

Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02.

Huang Y, Hong X, Hu J, Lu Q. Huang Y, et al. Onco Targets Ther. 2017 Jun 29;10:3233-3239. doi: 10.2147/OTT.S126819. eCollection 2017. Onco Targets Ther. 2017. PMID: 28721074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters